Circulating tumor cells count predicts survival in colorectal cancer patients

Journal of Gastrointestinal and Liver Diseases

Volumn 23, Issue 3, 2014, Pages 279-284

  Romiti, Adriana ^a   Raffa, Salvatore ^a   Di Rocco, Roberta ^a   Roberto, Michela ^a   Milano, Annalisa ^a   Zullo, Angelo ^b   Leone, Laura ^a   Ranieri, Danilo ^a   Mazzetta, Francesca ^a   Medda, Emanuela ^c   Sarcina, Ida ^a   Barucca, Viola ^a   D'Antonio, Chiara ^a   Durante, Valeria ^a   Ferri, Mario ^a   Torrisi, Maria Rosaria ^a   Marchetti, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Digestive Endoscopy Unit   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Circulating tumor cells; Colorectal cancer; Predictive value; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CIRCULATING TUMOR CELL; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SCORING SYSTEM; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR RECURRENCE;

EID: 84929940304     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: 10.15403/jgld.2014.1121.233.arom1     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Ferlay J, Parkin DM, Stelianova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:763-781.
3. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.
4. Van Cutsem E, Köhne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009;360:1408-1417.
5. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-791.
6. Danila DC, Heller G, Gignac GA, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007;13:7053-7058.
7. Sastre J, Maestro ML, Puente J, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008;19:935-938.
8. Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:3213-3221.
9. Cohen SJ, Punt CJ, Iannotti N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009;20:1223-1229.
10. Tol J, Koopman M, Miller MC, et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 2010;21:1006-1012.
11. Rossi Del Monte S, Ranieri D, Mazzetta F, et al. Free peritoneal tumor cells detection in gastric and colorectal cancer patients. J Surg Oncol 2012;106:17-23.
12. Gazzaniga P, Raimondi C, Gradilone A, et al. Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? J Cancer Res Clin Oncol 2013;139:1411-1416.
13. Dotan E, Cohen SJ, Alpaugh KR, Meropol NJ. Circulating tumor cells: evolving evidence and future challenges. Oncologist 2009;14:1070-1082.
14. Königsberg R, Gneist M, Jahn-Kuch D, et al. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Lett 2010;293:117-123.
15. Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010;138:1714-1726.
16. Lu Cy, Uen YH, Tsai HL, et al. Molecular detection of persistent postoperative circulating tumor cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Br J Cancer 2011;104:1178-1184.
17. Maestro LM, Sastre J, Rafael SB, et al. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res 2009;29:4839-4843.
18. Gazzaniga P, Gianni W, Raimondi C, et al. Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumour Biol 2013;34:2507-2509.
19. Thorsteinsson M, Jess P. The clinical significance of circulating tumor cells in non-metastatic colorectal cancer-a review. Eur J Surg Oncol 2011;37:459-465.
20. NCCN Guidelines: www.nccn.org/professionals/physician_gls/pdf/ colon.pdf
21. Labianca R, Nordlinger B, Beretta GD, et al; ESMO Guidelines Working Group. Early colon cancer: ESMO Clinical Practice Guidelinesfor diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi64-vi72.